Tema Heart & Health ETF HRTS
39.24 USD +0.21 (+0.55%)
Regular-session close
39.24 0.00 0.00%
After hours · Nov 13, 4:00 PM ET
39.24 Day range 39.24
32.59 52-week range 39.84
- YTD
- +11.20%
- 1 year
- +14.28%
News
benzinga.com From Shingles To Superbugs: Eli Lilly Expands Infectious Disease Push In Billion-Dollar Buying Wave Eli Lilly acquires Curevo, LimmaTech, and Vaccine Co. to expand its infectious disease portfolio and advance long-term disease prevention.
benzinga.com Why Is Eli Lilly Stock Gaining Today? Eli Lilly shares surged after FDA approval of its oral obesity drug Foundayo, boosting growth prospects in the weight-loss market.
benzinga.com 'Roche Restricts Consulting Work With Big Four Firms To Cut Costs' - Bloomberg https://www.bloomberg.com/news/articles/2026-03-24/roche-restricts-consulting-work-with-big-four-firms-to-cut-costs?utm_source=latest&utm_medium=share&utm_campaign=copy
benzinga.com Ultragenyx's Gene Therapy Study Shows Ammonia Reduction In Rare Metabolic Disorder Ultragenyx Phase 3 gene therapy data shows reduced ammonia levels in rare disease patients, with further results expected in 2027.